Abstract: A respirator is disclosed. The respirator includes a mask body and a harness. The mask body includes polypropylene in an amount of between 60 and 100 weight percent. The harness is attached to the mask body. The harness includes elastomeric polypropylene-miscible copolymer in an amount of between 80 and 100 weight percent. The respirator includes an overall composition of polypropylene of at least 80 weight percent. The respirator includes an overall composition of ethylene of less than 10 weight percent. The respirator may be consistent with definition of recyclable according to Association of Plastic Recyclers (APR) standards for polypropylene.

Abstract: An integrated circuit (IC) device includes a first IC chip, a second IC chip, and a chip-to-chip interface connected between the first IC chip and the second IC chip. The chip-to-chip interface communicates an interface clock signal and a logic clock signal between the first IC chip and the second IC chip. The interface clock signal is synchronous with a data signal received by one of the first IC chip and the second IC chip. The logic clock signal is asynchronous with the data signal.

Abstract: A panel adjustment assembly for a panel of a vehicle includes a first bracket fixedly coupled to the panel. The first bracket includes a first receiving opening coaxial with a first longitudinal axis. A second bracket has a second longitudinal axis and a channel coaxial with the first longitudinal axis and a second receiving opening coaxial with the second longitudinal axis. A first adjuster coaxial with the first longitudinal axis is coupled through the second bracket and into the first receiving opening in the first bracket, said first adjuster adjusting a first gap between the first bracket and the second bracket. A second adjuster is disposed within the receiving channel and partially within the second bracket. The second adjuster has a locating pin extending therefrom and is received within the vehicle. The second adjuster adjusts a second gap between the vehicle and the second bracket.

Abstract: The present disclosure provides a method of preparing a pharmaceutical composition. The method includes transferring a predetermined quantity of an excipient mixture from a second vessel to a first vessel. The excipient mixture transferred from the second vessel includes a liquid-state second quantity of a hydrofluoroalkane propellant and a first solubilized excipient comprising a low-molecular weight poly(ethylene oxide) polymer. The method further includes contacting at least one pharmaceutically-active compound with the excipient mixture under conditions that facilitate forming an intermixture comprising the propellant, the polymer, and the compound. Before transferring the excipient mixture, the first vessel contains a vapor-phase first quantity of the hydrofluoroalkane propellant and an effective amount of the at least one pharmaceutically-active compound.

Abstract: The present disclosure provides a method of preparing a pharmaceutical composition. The method includes transferring a predetermined quantity of an excipient mixture from a second vessel to a first vessel. The excipient mixture transferred from the second vessel includes a liquid-state second quantity of a hydrofluoroalkane propellant and a first solubilized excipient comprising a low-molecular weight poly(ethylene oxide) polymer. The method further includes contacting at least one pharmaceutically-active compound with the excipient mixture under conditions that facilitate forming an intermixture comprising the propellant, the polymer, and the compound. Before transferring the excipient mixture, the first vessel contains a vapor-phase first quantity of the hydrofluoroalkane propellant and an effective amount of the at least one pharmaceutically-active compound.

Abstract: A vehicle wireless information system includes a vehicle, an onboard vehicle computer provided in the vehicle and at least one external access point adapted to wirelessly access the onboard vehicle computer.

Abstract: Compositions containing albuterol, ipratropium, and a propellant as well as aerosol canisters and inhalers, such as metered dose inhalers, containing such compositions.

Abstract: The present disclosure provides a method of preparing a pharmaceutical composition. The method includes transferring a predetermined quantity of an excipient mixture from a second vessel to a first vessel. The excipient mixture transferred from the second vessel includes a liquid-state second quantity of a hydrofluoroalkane propellant and a first solubilized excipient comprising a low-molecular weight poly(ethylene oxide) polymer. The method further includes contacting at least one pharmaceutically-active compound with the excipient mixture under conditions that facilitate forming an intermixture comprising the propellant, the polymer, and the compound. Before transferring the excipient mixture, the first vessel contains a vapor-phase first quantity of the hydrofluoroalkane propellant and an effective amount of the at least one pharmaceutically-active compound.

Abstract: An electrical port is integrated within a side view mirror assembly of an automotive vehicle. The electrical port is electrically connected with a charging system of the vehicle. The electrical port may be coupled with a power source remote from the vehicle to power the charging system. The electrical port may be concealed or exposed depending on a position of the side view mirror assembly.

Abstract: The present invention is generally directed to a retractable overhead charging cord dispenser which has multi-positioning capability to provide plug-in electric power to PHEVs parked at various positions in a garage or the like. An illustrative embodiment of the retractable overhead charging cord dispenser includes an arm assembly, a cord guide arm carried by the arm assembly, a cord storage device provided in the arm assembly and a retractable charging cord extendable from the cord storage device and extending through and protruding from the cord guide arm.

Abstract: A vehicle wireless information system includes a vehicle, an onboard vehicle computer provided in the vehicle and at least one external access point adapted to wirelessly access the onboard vehicle computer.

Abstract: The present invention is generally directed to a retractable overhead charging cord dispenser which has multi-positioning capability to provide plug-in electric power to PHEVs parked at various positions in a garage or the like. An illustrative embodiment of the retractable overhead charging cord dispenser includes an arm assembly, a cord guide arm carried by the arm assembly, a cord storage device provided in the arm assembly and a retractable charging cord extendable from the cord storage device and extending through and protruding from the cord guide arm.

Abstract: Methods, compounds, and medicinal formulations utilizing biocompatible polymers for delivery of a drug, particularly for solubilizing, stabilizing and/or providing sustained release of drug from topical, implantable, and inhalation systems. Many of the methods, compounds, and medicinal formulations are particularly suitable for oral and/or nasal inhalation and use polymers of the formula —[X—R1—C(O)]— wherein each R1 is an independently selected organic group that links the —X— group to the carbonyl group, and each X is independently oxygen, sulfur, or catenary nitrogen.

Abstract: An electrical port is integrated within a side view mirror assembly of an automotive vehicle. The electrical port is electrically connected with a charging system of the vehicle. The electrical port may be coupled with a power source remote from the vehicle to power the charging system. The electrical port may be concealed or exposed depending on a position of the side view mirror assembly.

Abstract: Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.

Abstract: Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.

Abstract: A pharmaceutical suspension aerosol formulation containing HFA-227 as a propellant.

Abstract: Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.

Abstract: Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.

Abstract: Pharmaceutical suspension aerosol formulations containing a therapeutically effective amount of a drug and HFC 134a, HFC 227, or a mixture thereof.